Announcement
09 Oct 2020
On 9 October 2020, the U.S. Administration awarded $430 million to AstraZeneca for the late-stage development and large-scale manufacturing of COVID-19 therapeutic.
Source
Sign in to access
Number of interventions
1
1 certainly harmful
0 likely harmful
0 liberalising
List of interventions
Implementation date
09 Oct 2020
Revocation date:
No revocation date
Updated: 09 Oct 2020
Financial grant
In force
On 9 October 2020, as part of the operation warp speed goals, the U.S. Department of Health and Human Services (HHS) and Department of Defense announced awarding USD 486 million to AstraZeneca for the...
Sign in to see more
Threads
See all
This state act is not part of any Thread yet.